RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENTA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Enanta Pharmaceuticals stock price down 2.65% on Friday
(Updated on Jul 19, 2024)

Buy or Hold candidate since Jun 27, 2024 Gain 13.02% PDF

The Enanta Pharmaceuticals stock price fell by -2.65% on the last day (Friday, 19th Jul 2024) from $14.71 to $14.32. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 4.17% from a day low at $14.26 to a day high of $14.85. The price has risen in 6 of the last 10 days and is up by 6.95% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -142 thousand shares and in total, 99 thousand shares were bought and sold for approximately $1.42 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.68% during the next 3 months and, with a 90% probability hold a price between $12.90 and $18.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENTA Signals & Forecast

The Enanta Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.50. On a fall, the stock will find some support from the long-term average at approximately $13.33. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 15, 2024, and so far it has fallen -13.42%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.91 and $12.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enanta Pharmaceuticals finds support just below today's level at $12.91. If this is broken, then the next support from accumulated volume will be at $12.47 and $11.93.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.595 between high and low, or 4.17%. For the last week the stock has had daily average volatility of 6.81%.

Our recommended stop-loss: $13.78 (-3.78%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 20 days ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Enanta Pharmaceuticals to open at $14.48, and during the day (based on 14 day Average True Range), to move between $13.45 and $15.19, which gives a possible trading interval of +/-$0.87 (+/-6.05%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.60 (1.96%) than the support at $12.91 (9.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Enanta Pharmaceuticals stock A Buy?

Enanta Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.166 Hold/Accumulate Unchanged

Predicted Opening Price for Enanta Pharmaceuticals of Monday, July 22, 2024

Fair opening price July 22, 2024 Current price
$14.48 ( 1.08%) $14.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENTA

Fibonacci Support & Resistance Levels

Level Price
R3 15.07 5.24%
R2 14.84 3.65%
R1 14.70 2.67%
Price 14.32
S1 14.25 -0.505%
S2 14.11 -1.49%
S3 13.88 -3.07%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.54 15.50%
R2 16.00 11.73%
R1 14.60 1.96%
Price 14.32
S1 12.91 -9.85%
S2 12.47 -12.92%
S3 11.93 -16.69%

FAQ

What is the symbol for Enanta Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enanta Pharmaceuticals is ENTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.

What's the current price of Enanta Pharmaceuticals Stock?
As of the end of day on the Jul 19, 2024, the price of an Enanta Pharmaceuticals (ENTA) share was $14.32.

What is the 52-week high and low for Enanta Pharmaceuticals Stock?
The 52-week high for Enanta Pharmaceuticals Stock is $20.02 and the 52-week low is $8.08.

What is the market capitalization of Enanta Pharmaceuticals Stock?
As of the Jul 19, 2024, the market capitalization of Enanta Pharmaceuticals is 303.289M.

When is the next earnings date for Enanta Pharmaceuticals?
The upcoming earnings date for Enanta Pharmaceuticals is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT